Effect of extracorporeally induced total body hyperthermia for cancer on cardiovascular function.
- 1 January 1984
- journal article
- research article
- Published by International Heart Journal (Japanese Heart Journal) in Japanese Heart Journal
- Vol. 25 (6) , 993-1000
- https://doi.org/10.1536/ihj.25.993
Abstract
Total body hyperthermia (TBHT) was induced in patients with terminal cancer, using a femoral arterio-venous shunt as an extracorporeal circuit incorporation a heat exchanger. A total of 31 systemic hyperthermic terms lasting 3-4 h at 41.5.degree. to 42.degree. C (rectal temperature) were performed on 11 patients; chemotherapy was previously unsuccessful in all of these cases. The effect of TBHT on cardiovascular function was explored in these patients. The heart rate and cardiac output was always markedly increased during hyperthemia, however, the peripheral arterial, central venous, pulmonary arterial and pulmonary wedge pressures were little affected and no progressive metabolic acidosis occurred. TBHT was generally well tolerated and there as no instance in which this treatment was terminated because of severe cardiovascular failure during hyperthermia.This publication has 5 references indexed in Scilit:
- The effects of total-body hyperthermia combined with anticancer drugs on immunity in advanced cancer patientsCancer, 1983
- WHOLE-BODY HYPERTHERMIA AND CHEMOTHERAPY FOR TREATMENT OF PATIENTS WITH ADVANCED, REFRACTORY MALIGNANCIES1982
- Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermiaThe Journal of Thoracic and Cardiovascular Surgery, 1979
- Systemic thermotherapy: Description of a method and physiologic tolerance in clinical subjectsCancer, 1977
- Effect of hyperthermia on malignant cellsin vivo: A review and a hypothesisCancer, 1977